Daewoong Pharma
KRX:069620

Watchlist Manager
Daewoong Pharma Logo
Daewoong Pharma
KRX:069620
Watchlist
Price: 129 100 KRW 0.08% Market Closed
Market Cap: 1.5T KRW
Have any thoughts about
Daewoong Pharma?
Write Note

Daewoong Pharma
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Daewoong Pharma
Cash from Financing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Daewoong Pharma
KRX:069620
Cash from Financing Activities
â‚©168.5B
CAGR 3-Years
48%
CAGR 5-Years
N/A
CAGR 10-Years
18%
Yuhan Corp
KRX:000100
Cash from Financing Activities
â‚©55.5B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
SK Biopharmaceuticals Co Ltd
KRX:326030
Cash from Financing Activities
â‚©6.6B
CAGR 3-Years
-77%
CAGR 5-Years
-46%
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Cash from Financing Activities
-â‚©76.3B
CAGR 3-Years
14%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Cash from Financing Activities
â‚©61.5B
CAGR 3-Years
30%
CAGR 5-Years
32%
CAGR 10-Years
N/A
C
Celltrion Pharm Inc
KOSDAQ:068760
Cash from Financing Activities
-â‚©28.9B
CAGR 3-Years
-17%
CAGR 5-Years
-31%
CAGR 10-Years
N/A
No Stocks Found

Daewoong Pharma
Glance View

Market Cap
1.5T KRW
Industry
Pharmaceuticals

Daewoong Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceuticals. The company is headquartered in Hwaseong, Gyeonggi-Do. The company went IPO on 2002-11-01. The firm's products mainly include antihypertensive drugs, antianemic agents, antidiabetic agents, antiemetic agents, antihistamine agents, antimicrobials, antineoplastics, antiobesity agents, antipyretic agents, analgesic agents, anti-inflammatory agents, biosimilars, remedies for bone and joint diseases, cardiovascular treatments, central nervous system treatments, digestive agents, dermatologic agents, gastrointestinal agents, health supplements and respiratory remedies, among others. The firm distributes its products in domestic and overseas markets.

Intrinsic Value
213 530.48 KRW
Undervaluation 40%
Intrinsic Value
Price

See Also

What is Daewoong Pharma's Cash from Financing Activities?
Cash from Financing Activities
168.5B KRW

Based on the financial report for Sep 30, 2024, Daewoong Pharma's Cash from Financing Activities amounts to 168.5B KRW.

What is Daewoong Pharma's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
18%

Over the last year, the Cash from Financing Activities growth was 1 233%. The average annual Cash from Financing Activities growth rates for Daewoong Pharma have been 48% over the past three years , and 18% over the past ten years .

Back to Top